Leonard Avruch
Papers
1
Total Citations
9
H-Index
1
About
Leonard Avruch is a leading figure in the field of stereotactic ablative radiotherapy (SABR), with a particular focus on the technical precision and clinical integration of image-guided radiation therapy. His research centers on the development and validation of advanced fiducial markers—tiny implantable seeds that act as beacons for tumor tracking. Avruch’s most cited work, a 2015 study on platinum fiducial seeds, demonstrated their feasibility and superior detectability on both MRI and orthogonal X-ray images for real-time tumor tracking during CyberKnife SABR. This contribution has been foundational for improving the accuracy of radiation delivery, directly impacting the safety and efficacy of treatments for moving tumors. With 9 citations, this paper is a key reference for clinicians and physicists working on MRI/CT fusion and motion management. Avruch’s achievements include advancing the clinical workflow for robotic SABR, ensuring that fiducial placement is both practical and reliable for patients. His work bridges the gap between engineering and oncology, making him a respected voice in the ongoing effort to refine non-invasive cancer therapies.
Research Focus
Key Achievements
Top Papers
- 1